Mechanistically, these authors showed that a low expression of miR-92 in melanoma CSCs is associated with the activation of the integrin α/TGF-β axis to promote intratumoral immunosuppression and enhance tumorigenesis [288]. This evidence concerns the gene TGFB1 and melanoma.